Cite
HARVARD Citation
Marsh, K. et al. (2020). Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven®) utilization at a large academic medical center. Therapeutic advances in cardiovascular disease. p. . [Online].